AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.39%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$2.64B
AUM Growth
+$2.64B
(-30%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-44.32%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
281
New
59
Increased
39
Reduced
77
Closed
79
Top Buys
| 1 |
GE HealthCare
GEHC
|
$33.6M |
| 2 |
McDonald's
MCD
|
$30.3M |
| 3 |
ImmunityBio
IBRX
|
$20.5M |
| 4 |
GitLab
GTLB
|
$14.6M |
| 5 |
MongoDB
MDB
|
$12.3M |
Top Sells
| 1 |
Exact Sciences
EXAS
|
$54.8M |
| 2 |
Spectrum Brands
SPB
|
$49.4M |
| 3 |
Simply Good Foods
SMPL
|
$46.6M |
| 4 |
Sensient Technologies
SXT
|
$43.9M |
| 5 |
FibroGen
FGEN
|
$43.3M |
Sector Composition
| 1 | Healthcare | 69.03% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Technology | 10.97% |
| 4 | Consumer Staples | 3.25% |
| 5 | Communication Services | 2.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
RH
RH
$4.23B
| $4.21M | 0.07% |
22,292
-50,274
| -69% | -$9.5M |
|
102
Wynn Resorts
WYNN
$13B
| $4.2M | 0.07% |
+44,857
| New | +$4.2M |
|
103
Arvinas
ARVN
$568M
| $4.12M | 0.07% |
+560,000
| New | +$4.12M |
|
104
Deckers Outdoor
DECK
$18.2B
| $3.97M | 0.07% |
38,516
-42,970
| -53% | -$4.43M |
|
105
Amer Sports
AS
$21.1B
| $3.93M | 0.07% |
101,309
-7,685
| -7% | -$298K |
|
106
Alto Neuroscience
ANRO
$99.6M
| $3.57M | 0.06% |
1,624,000
+24,000
| +2% | +$52.8K |
|
107
Levi Strauss
LEVI
$8.95B
| $3.51M | 0.06% |
190,000
-30,000
| -14% | -$555K |
|
108
Best Buy
BBY
$15.6B
| $3.31M | 0.06% |
49,373
-22,771
| -32% | -$1.53M |
|
109
AstraZeneca
AZN
$249B
| $3.28M | 0.06% |
47,000
+23,000
| +96% | +$1.61M |
|
110
Mobix Labs
MOBX
$66.4M
| $3.27M | 0.06% |
+4,276,000
| New | +$3.27M |
|
111
Glaukos
GKOS
$5.5B
| $3.25M | 0.06% |
+31,438
| New | +$3.25M |
|
112
Nektar Therapeutics
NKTR
$553M
| $3.2M | 0.06% |
124,000
-912,000
| -88% | -$23.6M |
|
113
Vera Therapeutics
VERA
$1.44B
| $3.2M | 0.06% |
136,000
-164,000
| -55% | -$3.86M |
|
114
Eli Lilly
LLY
$659B
| $3.04M | 0.05% |
3,898
+3,583
| +1,137% | +$2.79M |
|
115
PDS Biotechnology
PDSB
$58.3M
| $2.97M | 0.05% |
2,236,000
-2,183,000
| -49% | -$2.9M |
|
116
AvePoint
AVPT
$3.47B
| $2.9M | 0.05% |
+150,000
| New | +$2.9M |
|
117
Victoria's Secret
VSCO
$1.79B
| $2.87M | 0.05% |
155,000
+35,000
| +29% | +$648K |
|
118
LivaNova
LIVN
$3.11B
| $2.75M | 0.05% |
+61,000
| New | +$2.75M |
|
119
Crocs
CROX
$4.94B
| $2.6M | 0.04% |
+25,685
| New | +$2.6M |
|
120
Spyre Therapeutics
SYRE
$996M
| $2.57M | 0.04% |
172,000
-28,000
| -14% | -$419K |
|
121
Mineralys Therapeutics
MLYS
$1.91B
| $2.41M | 0.04% |
+178,000
| New | +$2.41M |
|
122
Capri Holdings
CPRI
$2.45B
| $2.39M | 0.04% |
135,000
| – | – |
|
123
BJ's Restaurants
BJRI
$742M
| $2.23M | 0.04% |
50,000
| – | – |
|
124
Conduent
CNDT
$434M
| $2.21M | 0.04% |
+836,000
| New | +$2.21M |
|
125
Spotify
SPOT
$142B
| $2.16M | 0.04% |
2,816
-2,243
| -44% | -$1.72M |
|